References
- Buggio L, Aimi G, Vercellini P. Hemoperitoneum Following Sexual Intercourse in a Woman with Deep Infiltrating Endometriosis. Gynecol Obstet Invest. 2016;81:559–562.
- Lier MCI, Malik RF, Ket JCF, et al. Spontaneous hemoperitoneum in pregnancy (SHiP) and endometriosis - A systematic review of the recent literature. Eur J Obstet Gynecol Reprod Biol. 2017;219:57–65.
- Lee SR, Yi KW, Song JY, et al. Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma. Reprod Sci. 2018;25:341–346.
- Köhler G, Göretzlehner G, Rudolf K, et al. The effect of a single midcycle administration of 0.5 or 2.0 mg dienogest (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9-dien-3-one) on pituitary and ovarian function-investigation for the use as a postcoital contraceptive. Exp Clin Endocrinol. 1984;84:299–304.
- Togami S, Kobayashi H, Haruyama M, et al. A very rare case of endometriosis presenting with massive hemoperitoneum. J Minim Invasive Gynecol. 2015;22:691–693.
- Mutihir JT, Nyango DD. Massive haemoperitoneum from endometriosis masquerading as ruptured ectopic pregnancy: case report. Niger J Clin Pract. 2010;13:477–479.
- Taylor HS. Clinical diagnosis of endometriosis and optimal medical therapy. Fertil Steril. 2017;108:759–760.